ArticleItalian journal of pediatrics2026
Past diseases history: an important predictor of persistent learning disability in US children.
Article in Italian journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveWe aimed to analyse the role of past diseases history (PDH), including developmental delay (DD), autism, intellectual disability (ID), attention deficit disorder (ADD) / attention-deficit/hyperactivity disorder (ADHD) and asthma in persistent learning disability (PLD) risk in children.
methods1952 children were recruited from the US National Health Interview Survey (NHIS) from 2019 to 2023 according to a predefined criteria. Logistic regression analysis was performed to detect the association between PDH and PLD risk. Threshold effect analysis was used to detect the threshold age point. Interaction and Joint effects analyses between age/sex and PDH with PLD risk was conducted. Receiver operating curve (ROC) analysis was used to investigate the single and incremental predictive value of PDH on PLD risk. Population attributable fraction (PAF) of PDH in PLD risk was computed. Sensitivity analyses were performed by sub-age/sex group analyses, repeated analyses after propensity score matching (PSM), and E-values to assess the potential impact of unmeasured confounders.
resultsHistory of DD, autism, ID, ADD/ADHD, and asthma were all significantly associated with increased PLD risk. ID history resulted in 13.25 more times of PLD risk. Increase of PDH numbers led to an elevating trend of PLD risk. Age over 8 years showed 6% decreasing trend of PLD risk (odds ratio (OR):0.94, 95% confidence interval (CI): 0.89–0.99), while age over 12 years showed a lower PLD risk (OR < 1). 3 past diseases and 2–11 years old group had 10.78 more times PLD risk (OR: 11.78, 95% CI: 3.50, 39.68) compared with that in 2–11 years old children without PDH. 2 past diseases and female group had 2.24 more times PLD risk (OR: 3.24, 95% CI: 1.61, 6.50) compared with that in female without PDH. 2–11 years old and female showed a stronger joint effect with past diseases numbers for predicting PLD. PDH numbers had a good discriminatory power for predicting PLD risk. Combined five past diseases history accounted for over 10% of PAF for PLD risk. ID and ADD/ADHD, and autism and asthma history were the top contributors to PLD risk in female and male, respectively. Sensitivity analyses yielded similar results.
conclusionsPDH showed good prediction, discriminatory power and certain contribution to PLD risk, while lower than 12 years old, female, and increased PDH numbers may be indicators of PLD susceptibility. Early warning of PDH may be needed in specific populations with learning disability (LD).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.